
|Videos|January 7, 2014
Biosimilar Interchangeability
Interchangeability designations for biosimilars would make therapy substitutions easier for pharmacists, noted Steven Lucio of Novation, but the FDA has said they will not grant an interchangeability status to a biosimilar upon initial approval.
Advertisement
Interchangeability designations for biosimilars would make therapy substitutions easier for pharmacists, noted Steven Lucio of Novation, but the FDA has said they will not grant an interchangeability status to a biosimilar upon initial approval.
This video was shot at the 2013 Academy of Managed Care Pharmacy in San Antonio, Texas.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Clears First Single-Inhaler Triple Therapy for Asthma
2
FDA Approves Capvaxive Expanded Indication to Include Children, Adolescents at Increased Risk for Pneumococcal Disease
3
FDA Clears the Way for First Generic Single-Dose Flu Treatment Ahead of 2026 Season
4
Elevating Precision Medicine in Breast Cancer Care
5
















































































































